1. Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers
   Christine Alewine et al, 2014, Molecular Cancer Therapeutics CrossRef
2. Polymorphisms of an oncogenic gene, mesothelin, predict the risk and prognosis of gastric cancer in a Chinese Han population
   Kuan Shen et al, 2022, Archives of Toxicology CrossRef
3. Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
   Takahiro Einama et al, 2017, EBioMedicine CrossRef
4. Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
   Jiang Lv et al, 2019, Journal of Hematology & Oncology CrossRef
5. Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells’ heterogeneity
   Yehuda Schlesinger et al, 2020, Nature Communications CrossRef
6. Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors
   Sören Weidemann et al, 2021, Biomedicines CrossRef
7. High expression of mesothelin in plasma and tissue is associated with poor prognosis and promotes invasion and metastasis in gastric cancer
   Suryendu Saha et al, 2023, Advances in Cancer Biology - Metastasis CrossRef
8. Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
   Raffit Hassan et al, 2016, Journal of Clinical Oncology CrossRef
9. Progress of CAR-T Therapy in Gastric Cancer
   桃 李, 2022, Advances in Clinical Medicine CrossRef
10. A Surgeon Involved in Basic Research - on the Occasion of Studying Abroad
    TOMOAKI ITO, 2023, Juntendo Medical Journal CrossRef
11. Role of mesothelin in carbon nanotube-induced carcinogenic transformation of human bronchial epithelial cells
    Xiaoqing He et al, 2016, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
12. Mesothelin-targeted CAR-T cell therapy for solid tumors
    Astero Klampatsa et al, 2021, Expert Opinion on Biological Therapy CrossRef
13. A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer
    Qiujin Shen et al, 2019, EBioMedicine CrossRef
14. Functional Genomic mRNA Profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types
    Laetitia E. Lamberts et al, 2015, Oncotarget CrossRef
15. Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects
    Yuankui Zhu et al, 2024, Pharmacological Research CrossRef
16. Cellular immunotherapy in gastric cancer: adoptive cell therapy and dendritic cell-based vaccination
    Elnaz Faghfuri et al, 2022, Immunotherapy CrossRef
17. CAR-T Cell Therapy—An Overview of Targets in Gastric Cancer
    Dominika Bębnowska et al, 2020, Journal of Clinical Medicine CrossRef
18. Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines
    Ya-Mei Wang et al, 2017, International Journal of Oncology CrossRef
19. Clinical impacts of mesothelin expression in gastrointestinal carcinomas
    Takahiro Einama et al, 2016, World Journal of Gastrointestinal Pathophysiology CrossRef
20. Challenges of Anti-Mesothelin CAR-T-Cell Therapy
    Xuejia Zhai et al, 2023, Cancers CrossRef